SCM
AMED

SG Capital Management’s Amedisys AMED Stock Holding History

SG Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-19,766
Closed -$5.23M – 68
2021
Q1 		$5.23M Buy
+19,766
New +$5.57M 1.54% 16
2020
Q4 		– Sell
-19,827
Closed -$4.69M – 59
2020
Q3 		$4.69M Buy
+19,827
New +$4.51M 1.35% 26

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

SG Capital Management's AMED Position: Q2 2021 in Review

SG Capital Management sold out of Amedisys (AMED) in Q2 2021, closing a stake of 19,766 shares — an estimated $5.23M sold.

SG Capital Management first reported a position in AMED in Q3 2020 and held it in 2 quarters. The position peaked at $5.23M in Q1 2021. 375 funds tracked by Wall St. Rank hold AMED as of Q2 2021.

  • SG Capital Management reported no remaining Amedisys position as of Q2 2021 after selling out during the quarter.
  • SG Capital Management sold 19,766 Amedisys shares in Q2 2021, an estimated $5.23M.
  • SG Capital Management first reported a position in Amedisys in Q3 2020 and held it in 2 quarters.
  • SG Capital Management's Amedisys position peaked at $5.23M in Q1 2021.
  • 375 funds tracked by Wall St. Rank held Amedisys as of Q2 2021.

Based on SG Capital Management's 13F filing for Q2 2021, filed 10 Aug 2021.